Skip to content
    Omnes Capital logo

    Omnes Capital

    Paris, FranceFounded 1999
    www.omnescapital.comLinkedIn
    Climate & EnergyData & AnalyticsHardware & Semiconductors

    Omnes Capital is a leading European private equity and infrastructure firm dedicated to the energy transition, investing in renewable energy, sustainable cities, and deeptech. Founded in 1999 and based in Paris, the firm manages over €6.7 billion in assets.

    33% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 8 prior). Average disclosed round size is $38.2M (across 33 rounds with reported amounts).

    Find people at Omnes Capital on Goldilocks AI

    Portfolio

    60

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    2

    Team

    Marc-Philippe BOTTE

    Marc-Philippe BOTTE

    Managing Partner

    Michael POLLAN

    Michael POLLAN

    Managing Partner

    Michel de LEMPDES

    Michel de LEMPDES

    Managing Partner

    Benjamin STREMSDOERFER

    Benjamin STREMSDOERFER

    Partner

    Camille MUELLER

    Camille MUELLER

    Partner

    Caroline YAMETTI

    Caroline YAMETTI

    Partner

    Fabien COLLANGETTES

    Fabien COLLANGETTES

    Partner

    François-Xavier DEDDE

    François-Xavier DEDDE

    Partner

    Gonzague de TREMIOLLES

    Gonzague de TREMIOLLES

    Partner - Head of Digital Infrastructure

    Grégoire SAMAIN

    Grégoire SAMAIN

    Partner, Head of Project Management and Client Servicing - Investor Relations

    Jean-Baptiste DELATTRE

    Jean-Baptiste DELATTRE

    Partner

    Lina ZOVIC

    Lina ZOVIC

    Partner - CFO

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    91 investments
    CompanyRoundAmountDate
    Planet A Foods logoPlanet A FoodsSeries A$15.4MSep 2026
    Lithosquare logoLithosquareSeed$25MJan 2026
    EnduroSat logoEnduroSatUnknown$205MJan 2026
    Caracol logoCaracolSeries B$40MOct 2025
    Caracol AM logoCaracol AMSeries A—Oct 2025
    Skynopy logoSkynopyUnknown—Jun 2025
    PROXIMA FUSION GMBH logoPROXIMA FUSION GMBHSeries A—Jun 2025
    EnduroSat logoEnduroSatSeries B—May 2025
    Quantum Systems logoQuantum SystemsSeries C—May 2025
    Sekoia logoSekoiaSeries B—Apr 2025
    Coave Therapeutics logoCoave TherapeuticsSeries A$33MJan 2025
    ARX logoARXSeries A—Jan 2025
    Coave Therapeutics logoCoave TherapeuticsSeries A$32MJan 2025
    Tissium logoTissiumSeries B—Jan 2025
    Sekoia logoSekoiaSeries B$28MJan 2025
    Qantev logoQantevSeries B—Oct 2024
    Carbyon logoCarbyonSeries A—Sep 2024
    Unseenlabs logoUnseenlabsSeries C—Feb 2024
    Planet A Foods logoPlanet A FoodsSeries A$15.4MFeb 2024
    Planet A Foods logoPlanet A FoodsSeries B$30MJan 2024
    Planet A Foods logoPlanet A FoodsSeries B$30MJan 2024
    Planet A Foods logoPlanet A FoodsSeries A$15.4MDec 2023
    Quantum Systems logoQuantum SystemsSeries B—Oct 2023
    AAgomabSeries B$100MOct 2023
    Corteria Pharmaceuticals logoCorteria PharmaceuticalsSeries A—Sep 2023
    Page 1 of 4

    Top Co-Investors

    Bpifrance12 shared
    Cherry Ventures8 shared
    World Fund7 shared
    Station F6 shared
    Seventure Partners6 shared
    European Innovation Council (EIC)6 shared
    Turenne Capital5 shared
    Kurma Partners5 shared
    XAnge5 shared
    Mudcake4 shared
    Nucleus Capital4 shared
    UI Investissement4 shared
    Boehringer Ingelheim Venture Fund4 shared
    Andera Partners4 shared
    Fountain Healthcare Partners4 shared
    Bayern Kapital4 shared
    Ventech4 shared
    CapHorn Invest3 shared
    Verve Ventures3 shared
    Heartcore Capital3 shared

    Last updated: 7 October 2026